The Trump administration is preparing to impose new 100% tariffs on some imported drugs from companies that have not reached agreements with the U.S. president to lower their prices in the United States. This move aims to pressure pharmaceutical companies to reduce drug costs for American consumers. The new tariffs are expected to affect a wide range of medications, potentially sparking debates within the international trade community.
